Is PolyPeptide Group AG stock a buy?

Yes, PolyPeptide Group AG pays dividends. Last time was Monday 2nd of May 2022 where the investors holding the stock on Thursday 28th of April 2022 were paid CHF0.3 per share. Over the last 1 times between 2022 and 2022, PolyPeptide Group AG has paid CHF0.3 with an average of CHF0.3 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for PolyPeptide Group AG 10 years ago, but if you had invested on Friday 10th of February 2023 when the price was CHF25.06, you would have made a profit of CHF1.969 per share or 7.86%

No, the average daily trading liquidity for PolyPeptide Group AG is CHF11 094 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

PolyPeptide Group AG has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.40, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for PolyPeptide Group AG to be medium [0.6 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.